https://i.ytimg.com/vi/XLDQ320MFOE/hqdefault.jpg
Source: YouTube
(MedPage Today) -- NEW ORLEANS -- The more intensive LDL cholesterol target guidelines recommended for secondary prevention in high-risk patients...
(MedPage Today) -- DENVER -- Treatment-resistant dermatomyositis improved significantly with the investigational TYK2/JAK1 inhibitor brepocitinib, according to a randomized trial....
(MedPage Today) -- NEW ORLEANS -- Evolocumab (Repatha) reduced risk of a first major cardiovascular (CV) event in patients with...
(MedPage Today) -- NEW ORLEANS -- A major advance for the treatment of intermediate-risk pulmonary embolism (PE) arrived with HI-PEITHO's...
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for...
(MedPage Today) -- Every week in the pediatric emergency department, I watch the consequences of adolescent substance use arrive through...
